Novo's kidney disease drug fails to improve blood pressure in phase 3, spurring $816M loss
Novo's kidney disease drug fails to improve blood pressure in phase 3, spurring $816M loss
gmasson
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *
